Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

281 trials

NCT07432334
Recruiting
CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
Phase 1 · Vietnam · 1 site
Registry update: 9 Jul 2026
NCT05029336
Recruiting
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
Phase 2 · United States · 1 site
Registry update: 14 Oct 2025
NCT06875960
Recruiting
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
Phase 4 · United States · 4 sites
Registry update: 9 Sept 2026
NCT07246096
Recruiting
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 25 Feb 2026
NCT07363590
Recruiting
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Phase 1 · Australia, Belgium, China, Colombia, Spain, Georgia, Italy, Japan, Moldova, Peru, Romania, Thailand · 24 sites
Registry update: 2 Nov 2026
NCT07311200
Recruiting
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
Phase 2 · China · 1 site
Registry update: 24 Apr 2026
NCT07371468
Recruiting
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Phase 1 · Argentina, Brazil, Germany, Spain, France, Italy, Japan, Panama, Poland, Taiwan · 24 sites
Registry update: 23 Jun 2026
NCT07201129
Recruiting
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Phase 3 · Bulgaria, Germany, Spain, Poland, Romania, United States · 45 sites
Registry update: 30 Jul 2026
NCT07276958
Recruiting
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Phase 1 · Australia, China, Japan · 10 sites
Registry update: 8 Oct 2026
NCT07348055
Recruiting
A Study of GR1803 in Systemic Lupus Erythematosus
Phase 1/2 · China · 1 site
Registry update: 10 Mar 2026
NCT07425730
Recruiting
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Not applicable · China · 1 site
Registry update: 28 Apr 2026
NCT07403097
Recruiting
Study of CD19 CAR-T Therapy for Refractory SLE
Phase 1 · China · 1 site
Registry update: 11 Feb 2026
NCT07331272
Recruiting
A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)
Phase 1 · China · 5 sites
Registry update: 2 Feb 2026
NCT07000110
Recruiting
Anifrolumab Malignancy and Serious Infections Study
Not applicable · Germany, Denmark, Spain, France · 4 sites
Registry update: 16 Sept 2026
NCT07318259
Recruiting
Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE
Phase 1 · China · 1 site
Registry update: 3 Feb 2026
NCT07413341
Recruiting
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 19 Oct 2026
NCT07251179
Recruiting
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
Not applicable · France · 1 site
Registry update: 20 Aug 2026
NCT07053800
Recruiting
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
Phase 2 · Brazil, United Kingdom, Greece, United States, Vietnam · 16 sites
Registry update: 30 Oct 2026
NCT06594068
Recruiting
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
Phase 4 · United States · 1 site
Registry update: 16 Sept 2026
NCT07339332
Recruiting
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
Early phase 1 · China · 1 site
Registry update: 14 Jan 2026

Ordered by registry start date. Freshness and sponsorship never change the order.